ClinConnect ClinConnect Logo
Search / Trial NCT05345015

High Frequency RF Current Effects on Muscle Pain and Function

Launched by ARISTOTLE UNIVERSITY OF THESSALONIKI · Apr 19, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Sport Injuries Tecar Therapy Low Back Pain Muscle Injury

ClinConnect Summary

This clinical trial is looking into how high frequency electrical currents, known as TECAR, can help reduce pain and improve movement in people with muscle injuries or chronic low back pain. Participants will be divided into two groups: one will receive the TECAR treatment, while the other will not. Researchers will assess how participants feel and move before the treatment, immediately after, and again at 24 and 48 hours later. They will also check in with participants 3 and 6 months after the treatment to see if the benefits last.

To join the study, participants must be 18 years or older and have either a recent muscle strain in the hamstring, quadriceps, or calf, or have been experiencing low back pain for at least half of the days over the past six months. However, those with certain other injuries, serious health issues, or who have been on specific medications recently may not be eligible. This trial is currently recruiting participants of all genders, and it's a great opportunity for those looking to find relief from pain and improve their physical function.

Gender

ALL

Eligibility criteria

  • Muscle injury group
  • Inclusion Criteria:
  • Acute hamstring or quadriceps or calf strain injury
  • Age above 18 years
  • Exclusion Criteria:
  • Other injury or musculoskeletal condition
  • Any observed organ dysfunctions
  • Receipt of medication or treatment for the past 3 months
  • Low back pain group
  • Inclusion criteria
  • Pain between bottom of ribs and buttock creases
  • Incidents for at least half the days in the past six months
  • Visual analogue pain score equal or greater than 4/10
  • Pain incidents for for less than half the days in the past six months
  • Exclusion Criteria:
  • radiographic evidence of inflammatory disease affecting the spine
  • fracture
  • important genetic structure abnormality in the spine
  • pregnancy
  • use of medication that might influence heart rate and/or blood pressure
  • psychiatric disorders
  • receipt of medication or treatment for the past 3 months
  • No neurologic deficits (sensory, motor, or reflexes)

About Aristotle University Of Thessaloniki

Aristotle University of Thessaloniki (AUTH) is a prestigious institution in Greece, renowned for its commitment to advancing knowledge and innovation in the field of clinical research. As a leading academic sponsor of clinical trials, AUTH leverages its extensive resources and expertise to conduct rigorous studies that contribute to the understanding of various medical conditions and the development of novel therapeutic interventions. The university fosters collaboration among multidisciplinary teams, ensuring adherence to the highest ethical standards and regulatory requirements while promoting scientific excellence and enhancing patient care.

Locations

Kavala, , Greece

Serres, , Greece

Patients applied

0 patients applied

Trial Officials

Eleftherios Kellis, Ph.D.

Principal Investigator

Professor

Thomas Apostolou, M.D.

Study Director

International Hellenic University

Paris Iakovidis, Ph.D.

Principal Investigator

International Hellenic University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials